Rhinovirus and COPD Exacerbations: A Pilot Study
Author Information
Author(s): Mallia Patrick, Simon D, Kebadze Tatiana, Parker Hayley L, Kon Onn M, Johnston Sebastian L
Primary Institution: Imperial College London
Hypothesis
Can an experimental model of rhinovirus infection induce exacerbations in COPD patients?
Conclusion
Experimental rhinovirus infection in COPD patients induces symptoms and lung function changes typical of an acute exacerbation and appears safe.
Supporting Evidence
- All subjects developed symptomatic colds with the lowest dose of virus tested.
- Significant increases in lower respiratory tract symptoms were observed.
- No severe exacerbations or adverse events occurred during the study.
Takeaway
The study shows that giving a cold virus to people with COPD can make them feel worse, just like a real cold would.
Methodology
A pilot virus dose escalating study was conducted to assess the safety and feasibility of rhinovirus infection in COPD patients.
Potential Biases
Potential bias due to small sample size and lack of control group.
Limitations
The study was limited to only 4 subjects, which may not represent the broader COPD population.
Participant Demographics
Participants were COPD patients aged 40-75, current or ex-smokers with significant smoking history.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website